OIL 6.82% 23.5¢ optiscan imaging limited

The International Association of Oral Pathologists (IAOP)...

  1. 2,916 Posts.
    lightbulb Created with Sketch. 180
    The International Association of Oral Pathologists (IAOP) Presents Dr. Camile Farah, Recipient of the IAOP President's Prize!

    We are honoured to announce that Dr. Camile Farah, CEO and Managing Director of Optiscan Imaging Ltd, has been awarded the prestigious IAOP President's Prize. This esteemed award recognizes researchers who make significant contributions to our understanding of diseases affecting the oral and maxillofacial region.

    Dr. Farah will be delivering a captivating lecture on June 26th titled "Oral Potentially Malignant Disorders - The Intersection of Molecular Genomics and Optical Imaging - A Paradigm Shift in Diagnosis and Management."

    In this lecture, Dr. Farah will delve into Optiscan's ground breaking advancements in diagnosing and managing oral potentially malignant disorders (OPMD). Traditionally, OPMD diagnosis relies on appearance and tissue samples. However, new genetic testing and advanced imaging techniques are providing a more precise picture, revolutionizing the field.

    Key highlights include:
    - Identification of Key Genes: Understanding genetic links to cancerous changes.
    - Distinguishing Precancerous Conditions: Enhancing targeted treatment and improving patient outcomes.
    - Innovative Imaging Techniques: Real-time, high-resolution visualization of oral tissues.

    A recent study published by Optiscan highlights the high diagnostic accuracy of our confocal laser endomicroscopy (CLE) technology for oral cancer and precancerous conditions:
    - Diagnostic Accuracy: 88.9%
    - Sensitivity: 86.8%
    - Specificity: 92%
    - Positive Predictive Value (PPV): 94.3%
    - Negative Predictive Value (NPV): 82.1%
    - Carcinoma Detection: 100% accuracy

    Join us to learn how these cutting-edge advancements are transforming the diagnosis and management of complex oral disorders. Dr. Farah’s research is paving the way for improved precision and better patient care.

    Don't miss this opportunity to gain insights from a leader in oral pathology research!


    https://www.linkedin.com/company/optiscan/posts/?feedView=all

 
watchlist Created with Sketch. Add OIL (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.015(6.82%)
Mkt cap ! $196.3M
Open High Low Value Volume
23.0¢ 24.5¢ 23.0¢ $277.1K 1.171M

Buyers (Bids)

No. Vol. Price($)
2 61499 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 150000 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
OIL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.